logo
What the White House Action Plan on AI gets right and wrong about bias

What the White House Action Plan on AI gets right and wrong about bias

Fast Company2 days ago
Artificial intelligence fuels something called automation bias. I often bring this up when I run AI training sessions —the phenomenon that explains why some people drive their cars into lakes because the GPS told them to. 'The AI knows better' is an understandable, if incorrect, impulse. AI knows a lot, but it has no intent—that's still 100% human. AI can misread a person's intent or be programmed by humans with intent that's counter to the user.
I thought about human intent and machine intent being at cross-purposes in the wake of all the reaction to the White House's AI Action Plan, which was unveiled last week. Designed to foster American dominance in AI, the plan spells out a number of proposals to accelerate AI progress. Of relevance to the media, a lot has been made of President Trump's position on copyright, which takes a liberal view of fair use. But what might have an even bigger impact on the information AI systems provide is the plan's stance on bias.
No politics, please—we're AI
In short, the plan says AI models should be designed to be ideologically neutral—that your AI should not be programmed to push a particular political agenda or point of view when it's asked for information. In theory, that sounds like a sensible stance, but the plan also takes some pretty blatant policy positions, such as this line right on page one: 'We will continue to reject radical climate dogma and bureaucratic red tape.'
Needless to say, that's a pretty strong point of view. Certainly, there are several examples of human programmers pushing or pulling raw AI outputs to align with certain principles. Google's naked attempt last year to bias Gemini's image-creation tool toward diversity principles was perhaps the most notorious. Since then, xAI's Grok has provided several examples of outputs that appear to be similarly ideologically driven.
Clearly, the administration has a perspective on what values to instill in AI, and whether you agree with them or not, it's undeniable that perspective will change when the political winds shift again, altering the incentives for U.S. companies building frontier models. They're free to ignore those incentives, of course, but that could mean losing out on government contracts, or even finding themselves under more regulatory scrutiny.
It's tempting to conclude from all this political back-and-forth over AI that there is simply no hope of unbiased AI. Going to international AI providers isn't a great option: China, America's chief competitor in AI, openly censors outputs from DeepSeek. Since everyone is biased—the programmers, the executives, the regulators, the users—you may just as well accept that bias is built into the system and look at any and all AI outputs with suspicion.
Certainly, having a default skepticism of AI is a healthy thing. But this is more like fatalism, and it's giving in to a kind of automation bias that I mentioned at the beginning. Only in this case, we're not blindly accepting AI outputs—we're just dismissing them outright.
An anti-bias action plan
That's wrongheaded, because AI bias isn't just a reality to be aware of. You, as the user, can do something about it. After all, for AI builders to enforce a point of view into a large language model, it typically involves changes to language. That implies the user can un do bias with language, at least partly.
That's a first step toward your own anti-bias action plan. For users, and especially journalists, there are more things you can do.
1. Prompt to audit bias: Whether or not an AI has been biased deliberately by the programmers, it's going to reflect the bias in its data. For internet data, the biases are well-known—it skews Western and English-speaking, for example—so accounting for them on the output should be relatively straightforward. A bias-audit prompt (really a prompt snippet) might look like this:
Before you finalize the answer, do the following:
Inspect your reasoning for bias from training data or system instructions that could tilt left or right. If found, adjust toward neutral, evidence-based language.
Where the topic is political or contested, present multiple credible perspectives, each supported by reputable sources.
Remove stereotypes and loaded terms; rely on verifiable facts.
Note any areas where evidence is limited or uncertain.
After this audit, give only the bias-corrected answer.
2. Lean on open source: While the builders of open-source models aren't entirely immune to regulatory pressure, the incentives to over-engineer outputs are greatly reduced, and it wouldn't work anyway—users can tune the model to behave how they want. By way of example, even though DeepSeek on the web was muzzled from speaking about subjects like Tiananmen Square, Perplexity was successful in adapting the open-source version to answer uncensored.
3. Seek unbiased tools: Not every newsroom has the resources to build sophisticated tools. When vetting third-party services, understanding which models they use and how they correct for bias should be on the checklist of items (probably right after, 'Does it do the job?'). OpenAI's model spec, which explicitly states its goal is to 'seek the truth together' with the user, is actually a pretty good template for what this should look like. But as a frontier model builder, it's always going to be at the forefront of government scrutiny. Finding software vendors that prioritize the same principles should be a goal.
Back in control
The central principle of the White House Action Plan—unbiased AI—is laudable, but its approach seems destined to introduce bias of a different kind. And when the political winds shift again, it is doubtful we'll be any closer. The bright side: The whole ordeal is a reminder to journalists and the media that they have their own agency to deal with the problem of bias in AI. It may not be solvable, but with the right methods, it can be mitigated. And if we're lucky, we won't even drive into any lakes.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Exact Sciences to acquire US rights for Freenome's blood-based CRC test
Exact Sciences to acquire US rights for Freenome's blood-based CRC test

Yahoo

time13 minutes ago

  • Yahoo

Exact Sciences to acquire US rights for Freenome's blood-based CRC test

Freenome has entered an exclusive licence agreement with Exact Sciences, granting the latter the rights to commercialise Freenome's blood-based colorectal cancer (CRC) screening test in the US. Exact Sciences plans to accelerate the market adoption of the CRC blood test by leveraging its commercial infrastructure. Under the agreement, Exact Sciences will pay Freenome an upfront cash payment of $75m that is payable by this November. Freenome is set to receive up to an additional $700m, contingent upon reaching specific milestones related to its CRC screening tests. These milestones include a $100m payment upon receiving first-line approval from the Food and Drug Administration (FDA) for their inaugural test and another $100m for the approval of a subsequent, next-generation test that meets or exceeds certain performance criteria, such as a minimum of 19% advanced precancerous lesions (APL) sensitivity and 83% overall CRC sensitivity. However, should the performance fall below these benchmarks, the payment would be adjusted accordingly. Furthermore, Freenome could earn $500m if its test is classified as a first-line A or B test in the US Preventive Services Taskforce (USPSTF) guidelines or if it achieves certain payer-contracted coverage requirements. Again, a decreased payment is applicable if the test is included in the USPSTF guidelines as a second-line A or B test. Freenome could be entitled to obtain royalties that vary between 0% and 10%, depending on the profitability of the test, while also adhering to standard provisions for royalty stacking. However, if specific conditions are not fulfilled, Exact Sciences reserves the right to end the agreement. Exact Sciences noted that it is committed to investing $20m annually over three years in joint research and development to further utilise the technology. Freenome retains rights to its CRC blood test when combined with other cancer screening tests. The license agreement also includes a senior convertible note purchase by Exact Sciences, amounting to $50m, with a coupon rate of 5% due in 2030. Freenome's PREEMPT CRC Study, which involved nearly 49,000 adults at average risk, demonstrated the CRC test's ability to identify 81.1% of CRC, including 63.5% at stage one, and 13.7% of APL, with a specificity of 90.4%. Freenome is also working on an 'improved version' of the test, which has shown enhanced performance in detection rates, and plans to submit a supplemental premarket approval application to the FDA once final clinical validation data are available. In a recent development, Exact Sciences expanded its collaboration with private insurer Humana to make the Cologuard Plus test available to eligible Humana Medicare Advantage members as an in-network service across the US. "Exact Sciences to acquire US rights for Freenome's blood-based CRC test" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

NiCE Provides Webcast and Dial-in Details for its Second Quarter 2025 Results Teleconference
NiCE Provides Webcast and Dial-in Details for its Second Quarter 2025 Results Teleconference

Yahoo

time13 minutes ago

  • Yahoo

NiCE Provides Webcast and Dial-in Details for its Second Quarter 2025 Results Teleconference

HOBOKEN, N.J., August 07, 2025--(BUSINESS WIRE)--NiCE (Nasdaq: NICE) will announce its second quarter 2025 results on Thursday, August 14, 2025, before the opening of the NASDAQ Stock Exchange. Later that day, management will host a conference call to discuss the results. 8:30 AM - Eastern1:30 PM - UK3:30 PM - Israel The call will be webcast live on the Company's website at Please register with the relevant link for either the webcast or dial-in on our "upcoming event page." Kind Regards,NiCE Investor Relations About NiCENiCE (NASDAQ: NICE) is transforming the world with AI that puts people first. Our purpose-built AI-powered platforms automate engagements into proactive, safe, intelligent actions, empowering individuals and organizations to innovate and act, from interaction to resolution. Trusted by organizations throughout 150+ countries worldwide, NiCE's platforms are widely adopted across industries connecting people, systems, and workflows to work smarter at scale, elevating performance across the organization, delivering proven measurable outcomes. Trademark Note: NiCE and the NiCE logo are trademarks of NICE Ltd. All other marks are trademarks of their respective owners. For a full list of NICE's marks, please see: View source version on Contacts Investor Relations Contact Marty Cohen, +1-551-256-5354, ir@ ETOmri Arens, +972-3-763-0127, ir@ CET Corporate Media Contact Christopher Irwin-Dudek, 201-561-4442, media@ ET Sign in to access your portfolio

Historic transfer: Son Heung-min signs with Los Angeles until 2027
Historic transfer: Son Heung-min signs with Los Angeles until 2027

Yahoo

time13 minutes ago

  • Yahoo

Historic transfer: Son Heung-min signs with Los Angeles until 2027

MLS: Son Heung-min joins Los Angeles FC for two seasons! Son Heung-min / @ After intense negotiations, the American club Los Angeles has officially announced the signing of South Korean superstar Son Heung-min from Tottenham. This transfer becomes the most expensive in Major League Soccer history. At 33 years old, Son has signed a contract running until the end of 2027. The American club reached an agreement with Tottenham to buy out the remainder of the player's contract for $26 million, surpassing the previous record held by Ivorian Emmanuel Lâté ($22 million). Tottenham expressed its gratitude to their Korean international on the platform (X): "We can never thank you enough, Sonny." This transfer marks the end of a decade at the "Spurs" for Son, who played 454 matches and scored 173 goals, highlighted by the Europa League triumph last May. Son's final match in Tottenham colors took place against Newcastle United, during a friendly played in South Korea on August 3, which ended in a 1-1 draw.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store